Literature DB >> 18344934

Early hyperglycemia after allogenic kidney transplantation: does it induce infections.

Mahbobeh Sadat Hosseini1, Eghlim Nemati, Vahid Pourfarziani, Saeed Taheri, Mohammad Hossein Nourbala, Behzad Einollahi.   

Abstract

BACKGROUND: Although impact of diabetes mellitus after solid organ transplantation is a broadly investigated issue, a potential impact of early hyperglycemia after renal transplantation has not received enough consideration. In this study, we aimed to evaluate the potential impact of early hyperglycemia on the hazards of infections development leading to re-hospitalization. MATERIAL/
METHODS: We evaluated 1931 non diabetic renal allograft recipients, undergone renal transplantation at the Baqiyatallah Hospital, Tehran from 1984 to 2006. Level of hyperglycemia was defined at 126 mg/dL. Patients who had at least two glucose concentration results over the mentioned level in two different days during their early post transplantation period were determined as hyperglycemic.
RESULTS: Overall, 7.6% of patients were determined as having early post transplant hyperglycemia. Multivariable hazard analysis using Cox regression model showed that early post transplantation hyperglycemia has an independent impact on rehospitalization of non-diabetic kidney allograft recipients for developing infectious diseases.
CONCLUSIONS: Regarding findings of our study and previous studies we conclude that renal transplant recipients who develop hyperglycemia during their early post transplantation period should receive higher amount of attention over their follow up periods.

Entities:  

Mesh:

Year:  2007        PMID: 18344934

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  8 in total

Review 1.  How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.

Authors:  S Fuji; A Rovó; K Ohashi; M Griffith; H Einsele; M Kapp; M Mohty; N S Majhail; B G Engelhardt; A Tichelli; B N Savani
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

2.  Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized Study.

Authors:  Amisha Wallia; Kathleen Schmidt; Diana Johnson Oakes; Teresa Pollack; Nicholas Welsh; Susan Kling-Colson; Suruchi Gupta; Candice Fulkerson; Grazia Aleppo; Neehar Parikh; Josh Levitsky; J P Norvell; Alfred Rademaker; Mark E Molitch
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

3.  Glycemic control by a glucose management service and infection rates after liver transplantation.

Authors:  Amisha Wallia; Neehar D Parikh; Eileen O'Shea-Mahler; Kathleen Schmidt; Anthony J DeSantis; Lu Tian; Josh Levitsky; Mark E Molitch
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

4.  Relative risk estimated from the ratio of two median unbiased estimates.

Authors:  Rickey E Carter; Yan Lin; Stuart R Lipsitz; Robert G Newcombe; Kathie L Hermayer
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2010-08-01       Impact factor: 1.864

Review 5.  The effect of diabetes on hospital readmissions.

Authors:  Kathleen M Dungan
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

Review 6.  Management of post-transplant diabetes.

Authors:  Ashley Therasse; Amisha Wallia; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

Review 7.  Management of the hospitalized transplant patient.

Authors:  Brian Boerner; Vijay Shivaswamy; Whitney Goldner; Jennifer Larsen
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

8.  Development of a Predictive Model for Hyperglycemia in Nondiabetic Recipients After Liver Transplantation.

Authors:  Henry Zelada; Lisa B VanWagner; Teresa Pollack; Devan Higginbotham; Lihui Zhao; Amy Yang; Mark E Molitch; Amisha Wallia
Journal:  Transplant Direct       Date:  2018-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.